Recent years have seen various reviews on the lack of access to radiotherapy often based on geographic regions of the world such as Africa, Asia Pacific, Europe, Latin America and North America. Countries are often defined by their national income per capita levels based on World Bank definitions of high income, upper middle income, lower middle income and low income. Within the world regions, there are significant variations in gross national income (GNI) per capita among the different countries, and even within similar income levels, large variations exist. This report presents the actual status of radiotherapy and analyses the current needs and costs to provide full access in the different regions of the world. Actual coverage of the needs ranges from 34% in Africa to over 92% in Europe to about double the needs in North America. In line with this, proportional additional investments and operational costs are as high as more than 200% in Africa to almost none in North America. Two world regions face substantial challenges: Africa, based on the important demands to build new capacity and subsequently to maintain operational capability; and Asia Pacific, due to its high population density, translating into large absolute needs in radiotherapy treatments and resources, and hence in associated costs. With the data highlighting a large variability of GNI/capita even within similar income levels in the various world regions, it is expected that additional investment in resources and costs may be more dependent on income level of the country than on the GNI group or the geographic region of the world.
Introduction
In recent years, a large body of evidence has emerged on the availability and needs of radiotherapy. In contrast to common expectations, considerable gaps in access to radiotherapy have not only been observed in low-and middle-income countries (LMICs) [1e6] , but also in most European countries. Although the latter region is typically considered a high-income region where resources and access consequently should be optimal, important variations have been observed in available human and capital resources, translating into variable gaps in radiotherapy provision [7e12] . The most comprehensive, worldwide, Author for correspondence: E. Zubizarreta, Applied Radiation Biology and Radiotherapy Section, International Atomic Energy Agency, Vienna International Centre, PO Box 100, 1400 Vienna, Austria.
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Clinical Oncology j o ur n a l h o m e p a ge : w w w . c l i n i c a l on c o l o gy o n l i ne . n e t [2, 10, 12, 13] . In most instances, the actual needs were estimated as the additional number of capital (mostly linear accelerators; linacs) and/or human resources required to allow full coverage of radiotherapy in a subset of countries or certain regions, based on generally accepted definitions on resource throughput and using various assumptions on other parameters such as operating hours [10, 12, 14, 15] . The GTFRCC report used a more refined time-driven activitybased costing (TD-ABC) approach that did not only allow computing investment and operational costs, but also provided insight into resource utilisation and shortfalls in coverage [2] . Although the number of additional machines needed varies between these reports, the overall conclusion is that around 50% of cases requiring radiotherapy in LMICs do not have access to treatment, and the figure of unavailable need rises to 90% in low-income countries (LICs).
Accurate data on the cost of radiotherapy remain scarce in today's literature. A recent systematic review of the available radiotherapy costing literature observed that only a minority of costing studies used conventional costing methodologies, which, together with the large heterogeneity in scope of the analyses and in inputs used and outputs reported, did not allow the presentation of a consistent picture of radiotherapy costs [16] . Moreover, only one of the studies in the review provided cost data for a range of different countries [17] . To date, the GTFRCC is the only report that has estimated the investment and operational costs for radiotherapy across the globe. To provide input to an investment model that would allow closing the gap in radiotherapy provision by 2035, the report focused on incremental costs to cover additional resources needed over the next 20 years [2] .
Here we present the current radiotherapy needs in LMICs, together with the investment and operational costs for optimal coverage to date. Moreover, being aware that LMICs are spread around different regions in the world, we analyse the needs and costs on the proportion of low-, lower middle-(L-MIC), upper middle-(U-MIC) and highincome (HIC) countries in the different world regions.
Countries and Regions
Countries were classified according to the definitions of the World Bank for 2017 [18] . For the current 2017 fiscal year, low-income economies are defined as those with a gross national income (GNI) per capita, calculated using the World Bank Atlas method, of US$1025 or less in 2015; lower middle-income economies are those with a GNI per capita between US$1026 and US$4035; upper middle-income economies are those with a GNI per capita between US$4036 and US$12 475; high-income economies are those with a GNI per capita of US$12 476 or more. The World Bank includes 217 economies, of which 79 are categorised as HIC, 55 as U-MIC, 52 as L-MIC and 31 as LIC. Forty-three small countries in this list are not reported by GLOBOCAN or DIRAC, hence they were not included in the analysis. 
Courses, Resources and Costs
The actual situation, based on today's available resources, was evaluated and compared with the optimal situation, where resources would match the needs to treat all patients with an indication for radiotherapy. Resources in the latter situation are further referred to as 'total resources' and the associated costs as 'total costs'.
Two previously published models were used. The total number of radiotherapy courses needed to treat all patients with an indication for radiotherapy to date was calculated using the evidence-based estimation method (EBEST) from the Collaboration for Cancer Outcomes Research and Evaluation (CCORE) [19e21] . The TD-ABC model developed for the GTFRCC [2], based on former IAEA activity-based costing and staffing models [22, 23] was used to compute the total resources needed to deliver these courses as well as to calculate the costs, actual and total investment and operational costs, and costs per course.
The main assumptions and input variables, which are largely in line with those used for the GTFRCC report [2], are described below.
Courses
Based on data from GLOBOCAN 2012 [24] , the number of current radiotherapy indications, for external beam
